- Home
- RYTM vs HOMB Comparison
RYTM vs HOMB Comparison
Compare RYTM & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- HOMB
- Stock Information
- Founded
- RYTM 2008
- HOMB 1998
- Country
- RYTM United States
- HOMB United States
- Employees
- RYTM N/A
- HOMB N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- HOMB Major Banks
- Sector
- RYTM Health Care
- HOMB Finance
- Exchange
- RYTM Nasdaq
- HOMB Nasdaq
- Market Cap
- RYTM 5.9B
- HOMB 5.8B
- IPO Year
- RYTM 2017
- HOMB 2006
- Fundamental
- Price
- RYTM $88.64
- HOMB $29.46
- Analyst Decision
- RYTM Strong Buy
- HOMB Hold
- Analyst Count
- RYTM 13
- HOMB 5
- Target Price
- RYTM $89.77
- HOMB $31.80
- AVG Volume (30 Days)
- RYTM 1.0M
- HOMB 1.2M
- Earning Date
- RYTM 08-05-2025
- HOMB 07-16-2025
- Dividend Yield
- RYTM N/A
- HOMB 2.69%
- EPS Growth
- RYTM N/A
- HOMB 14.00
- EPS
- RYTM N/A
- HOMB 2.19
- Revenue
- RYTM $136,863,000.00
- HOMB $1,008,649,000.00
- Revenue This Year
- RYTM $37.47
- HOMB $11.25
- Revenue Next Year
- RYTM $71.16
- HOMB $2.78
- P/E Ratio
- RYTM N/A
- HOMB $13.59
- Revenue Growth
- RYTM 48.88
- HOMB 3.77
- 52 Week Low
- RYTM $40.61
- HOMB $24.22
- 52 Week High
- RYTM $94.80
- HOMB $32.91
- Technical
- Relative Strength Index (RSI)
- RYTM 71.18
- HOMB 58.73
- Support Level
- RYTM $87.86
- HOMB $28.07
- Resistance Level
- RYTM $92.14
- HOMB $30.42
- Average True Range (ATR)
- RYTM 3.57
- HOMB 0.59
- MACD
- RYTM 1.01
- HOMB 0.04
- Stochastic Oscillator
- RYTM 77.38
- HOMB 76.17
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.